NICE director files initial Form 3 holdings

NICE Ltd. director Ben-Shaoul Rimon filed an initial Form 3 reporting his equity holdings in the company.

(Neutral)

Form Type

Rhea-AI Filing Summary

NICE Ltd. director Ben-Shaoul Rimon filed an initial Form 3 reporting his equity holdings in the company. He directly owns 995 Ordinary Shares and a series of employee stock options over additional Ordinary Shares with varying exercise prices and expiration dates.

These options include grants exercisable for 3,980 shares at an exercise price of 151.6300 per share expiring on April 30, 2026, and others such as 2,785 shares at 224.1800 per share expiring on September 10, 2026. Footnotes state that some options are fully vested and currently exercisable, while others vest in installments through September 30, 2026.

Insider Trade Summary

14 transactions reported

Mixed 14 txns

Insider Ben-Shaoul Rimon

Role Director

Type	Security	Shares	Price	Value
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Options — 22,895 contracts (Direct); Ordinary Shares — 995 shares (Direct)

Footnotes (3)

F1. The stock option is fully vested and currently exercisable.
F2. The stock option is vested and exercisable with respect to 746 Ordinary Shares and will vest with respect to the remaining shares in three substantially equal installments on March 30, 2026, June 30, 2026 and September 30, 2026.
F3. The stock option will vest on September 30, 2026.

FAQ

What does Ben-Shaoul Rimon’s Form 3 filing show for NICE Ltd. (NCSYF)?

The Form 3 shows director Ben-Shaoul Rimon’s initial equity holdings in NICE Ltd., including 995 Ordinary Shares and multiple stock option awards. These options cover additional Ordinary Shares at specified exercise prices and expiration dates, reflecting his existing compensation-related exposure to the company’s stock.

How many NICE Ltd. (NCSYF) Ordinary Shares does Ben-Shaoul Rimon directly own?

Ben-Shaoul Rimon directly owns 995 Ordinary Shares of NICE Ltd. This share position is in addition to several option grants that, if exercised, would provide rights to acquire more Ordinary Shares under defined terms and vesting schedules disclosed in the Form 3 filing.

What stock option positions are reported for Ben-Shaoul Rimon in NICE Ltd. (NCSYF)?

The filing lists several stock options over Ordinary Shares with different exercise prices and expirations, such as 3,980 underlying shares at 151.6300 expiring April 30, 2026. Each line describes a specific grant, indicating his potential future rights to acquire NICE Ordinary Shares.

Are Ben-Shaoul Rimon’s NICE Ltd. (NCSYF) options currently vested or still vesting?

Footnotes state that at least one stock option is fully vested and currently exercisable. Another option is vested and exercisable for 746 Ordinary Shares, with remaining shares vesting in three equal installments on March 30, 2026, June 30, 2026 and September 30, 2026, while another will vest on September 30, 2026.

Does the NICE Ltd. (NCSYF) Form 3 show any recent insider buying or selling by Ben-Shaoul Rimon?

The Form 3 presents holdings rather than new buy or sell transactions. Transaction codes are unknown and the entries are classified as holdings, indicating a snapshot of his existing Ordinary Share and option positions, not open-market purchases or sales activity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/18/2026 - 09:15 AM

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Ben-Shaoul Rimon

(Last)

(First)

(Middle)

221 RIVER STREET

(Street)

HOBOKEN

NEW JERSEY

07030

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
NICE Ltd. [ NICE ]

3a. Foreign Trading Symbol
[NICE.TA]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	995	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options	⁽¹⁾	04/30/2026	Ordinary Shares	3,980	$151.63	D
Options	⁽¹⁾	09/10/2026	Ordinary Shares	2,785	$224.18	D
Options	⁽¹⁾	09/10/2026	Ordinary Shares	696	$0.2929	D
Options	⁽¹⁾	04/28/2027	Ordinary Shares	2,214	$232.2005	D
Options	⁽¹⁾	04/28/2027	Ordinary Shares	554	$0.3076	D
Options	⁽¹⁾	06/22/2028	Ordinary Shares	2,516	$197.4245	D
Options	⁽¹⁾	06/22/2028	Ordinary Shares	629	$0.2887	D
Options	⁽¹⁾	07/17/2029	Ordinary Shares	2,086	$206.5232	D
Options	⁽¹⁾	07/17/2029	Ordinary Shares	521	$0.2751	D
Options	⁽¹⁾	07/03/2030	Ordinary Shares	2,545	$168.4643	D
Options	⁽¹⁾	07/03/2030	Ordinary Shares	636	$0.2657	D
Options	⁽²⁾	09/30/2031	Ordinary Shares	2,987	$144.903	D
Options	⁽³⁾	09/30/2031	Ordinary Shares	746	$0.3025	D

Explanation of Responses:

1. The stock option is fully vested and currently exercisable.

2. The stock option is vested and exercisable with respect to 746 Ordinary Shares and will vest with respect to the remaining shares in three substantially equal installments on March 30, 2026, June 30, 2026 and September 30, 2026.

3. The stock option will vest on September 30, 2026.

Remarks:

Exhibit 24 - Power of Attorney.

	/s/ Alon Levy, Attorney-in-Fact for Rimon Ben Shaoul	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR